Founded in the heart of China's medical technology hub, Xinkang Biomedical Technology (Hangzhou) Co., Ltd. has been at the forefront of rehabilitation innovation for over three decades. Our focus for the last 15 years has been exclusively on the R&D and manufacturing of high-end rehabilitation equipment, specifically as a premier NMES Unit manufacturer.
We provide a full-cycle closed loop from research to clinical application, ensuring every NMES unit produced meets the highest standards of safety and efficacy. Our systems are integrated into 75% of China's top-tier hospitals, proving our reliability in high-stakes medical environments.
Understanding Neuromuscular Electrical Stimulation in the Modern Era
The global market for Neuromuscular Electrical Stimulation (NMES) is experiencing a paradigm shift. Historically confined to sports medicine and specialized clinics, NMES technology is now becoming a cornerstone of geriatric care, neurological recovery, and post-surgical rehabilitation. With an aging global population and an increase in stroke-related conditions, the demand for reliable NMES Unit suppliers has reached an all-time high.
Industrial Trends:
Where Technology Meets Patient Care
In hospital settings, our NMES units are used for stroke survivors to prevent muscle atrophy and re-educate motor pathways during the critical recovery window.
Used by physiotherapists to stimulate the quadriceps post-ACL surgery, maintaining muscle mass without putting stress on the newly repaired ligament.
Combatting age-related sarcopenia in elderly patients who have limited mobility, improving their balance and reducing fall risks.
International procurement managers from the EU, North America, and Southeast Asia face complex challenges: quality consistency, regulatory compliance (CE/FDA), and cost-efficiency. As a leading NMES Unit manufacturer, Xinkang Biomedical addresses these needs through our robust Chinese supply chain.
The Chinese Factory Advantage:
Neuromuscular electrical stimulation is more than just current; it’s about precision. Our units utilize Compound Wave Dynamic Interference and Transcranial Stimulation technologies. By delivering specific pulse widths (50–400 µs) and frequencies (1–120 Hz), our devices selectively target motor neurons while minimizing sensory discomfort.
Our R&D Achievements:
We are a domestic leader in physical factor treatment products such as electrotherapy, light therapy, magnetic therapy, and spinal therapy products. Our "High Quality Assurance" is backed by national medical supervision and management certification.
Factory covers more than 10,000 square meters with over 200 employees and 30+ standard production lines.
Engineers with 10+ years experience in rehab medical equipment development and personalized customization.
We provide product training, sales courses, and after-sales maintenance to ensure our partners' long-term success.
As a professional pain management expert, Xinkang Biomedical is deeply engaged in the field of rehabilitation medicine. Our NMES units are not just electrical pulsers; they are sophisticated medical instruments designed through decades of academic cooperation with top research centers. We understand that in the clinical world, reliability is synonymous with patient safety. This is why our quality control standards reference international peers at every stage of the manufacturing process.
Our market reach speaks for itself. In the Chinese market, we have built a mature system integrating industry, teaching, research, and application. For the overseas market, we are rapidly expanding by providing high-quality OEM/ODM solutions that help our clients build strong brands. Whether it is a small rehabilitation clinic or a national healthcare tender, Xinkang Biomedical provides the technology and support necessary to improve human life through innovation.
For distributors looking for an NMES Unit manufacturer that offers independent R&D technology, leading domestic industry software, and a complete supply chain, Xinkang is the definitive choice. We welcome global partners to join us in revolutionizing rehabilitation technology.
MedTrack
